9 results
Algorithm for the Long-Term Treatment of Venous Thromboembolism 

Reference: https://doi.org/10.1182/blood.2019002364

by Dr. Clive Kearon and Dr. Susan
Algorithm for the ... Thromboembolism Reference ... Thromboembolism #VTE ... #Anticoagulation ... #Algorithm #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... with patients’ preference ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Anticoagulation
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Thromboembolism Treatment Algorithm ... Active malignancy ... #Management #VTE ... #DVT #Algorithm ... Treatment #Hematology #Anticoagulation
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... + Warfarin) Reference ... #DOAC #Dosing #Oral ... #Anticoagulation
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... body mass index; VTE ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Anticoagulation
►
Choice of anticoagulant for treatment of pulmonary embolism
 • Malignancy - LMWH
 • To avoid parenteral
pulmonary embolism • Malignancy ... • Once a day oral ... #decisionaid #vte ... #anticoagulation
Malignant Hyperthermia is a very rare, but life-threatening condition that can occur after using certain anesthetic
Malignant Hyperthermia ... anesthesiology #malignant ... management #treatment #algorithm ... References: ... Malignant hyperthermia
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Vasculitis Management Algorithm ... High-Dose Daily Oral ... Options in Order of Preference ... ACR2021 #Guidelines #algorithm
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
neuroexam - Oral ... event, follow ACC algorithm ... Anticoagulation ... • <3mo since VTE